Ophthalmology & Eye Diseases
Biologic therapies for eye diseases focus on preserving and restoring vision by reducing inflammation, promoting tissue regeneration, and protecting retinal cells. These therapies provide non-invasive options for managing chronic and degenerative eye conditions.
Common Conditions Treated
- Dry Eye Syndrome: Insufficient tear production causing irritation.
- Macular Degeneration: Degeneration of the central retina, often age-related.
- Diabetic Retinopathy: Retinal damage due to diabetes.
- Corneal Ulcers: Open sores on the cornea.
- Glaucoma: Damage to the optic nerve often caused by increased intraocular pressure.
Treatment Modalities
- Exosome Therapy: Injected or applied as eye drops to reduce inflammation and repair damaged tissue.
- Mesenchymal Stem Cell (MSC) Therapy: High-quality MSC-derived products regenerate retinal cells.
- Platelet-Rich Plasma (PRP): Used in topical formulations to enhance corneal healing.
Procedure Overview
Patient Selection:
- Ideal Candidates: Individuals with chronic or degenerative eye conditions.
- Contraindications: Active ocular infections or systemic immune disorders.
Preparation:
- Ophthalmic Examination: Baseline assessment of visual acuity and ocular health.
- Sterile Environment: Ensure sterile application to prevent infection.
Administration:
- Topical Applications: Eye drops containing biologics for surface conditions.
- Injection Therapy: Subconjunctival or intravitreal delivery for deeper issues.
Post-Treatment Care:
- Avoid touching the eyes or using contact lenses for 24 hours.
- Schedule follow-ups to monitor improvement.
Supporting Studies
- Exosome-Based Therapy in Dry Eye Disease: Demonstrates enhanced tear production and reduced inflammation. Read study
- MSC-Derived Exosomes for Retinal Repair: Highlights efficacy in treating retinal degenerative diseases. Read study